StockData
Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc. (RANI) income statement

RANINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3036% above fair value
$0.51−0.07 (-11.97%)

Close on Nov 20, 2026Market cap $71.24MP/E –Yield –

Rani Therapeutics Holdings, Inc. financial ratios

See a number that looks wrong?